Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
allogeneic adipose derived mesenchymal stem cell (2 trials)
platelet-rich plasma (1 trial)
Lung Diseases, Obstructive (Phase 2)
Osteoarthritis (Phase 2)
Osteoarthritis, Knee (Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Trials (2 total)
Trial APIs (2 total)